Stem Cells

The 11th Circuit ruled that it lacks jurisdiction over patients’ appeal to intervene in an action between a corporation running a stem cell “bank” and the U.S. Food and Drug Administration, which sued the bank to prevent it from distributing stem cell products until it obtains approval.

ATLANTA — The 11th Circuit ruled that it lacks jurisdiction over patients’ appeal to intervene in an action between a corporation running a stem cell “bank” and the U.S. Food and Drug Administration, which sued the bank to prevent it from distributing stem cell products until it obtains approval.

Categories / Appeals, Government, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.